EOF analysis of three records of sea-ice concentration spanning the last 30 years

Several continuous observational datasets of Artic sea-ice concentration are currently available that cover the period since the advent of routine satellite observations. We report on a comparison of three sea-ice concentration datasets. These are the National Ice Center charts, and two passive microwave radiometer datasets derived using different approaches: the NASA team and Bootstrap algorithms. Empirical orthogonal function (EOF) analyses were employed to compare modes of variability and their consistency between the datasets. The analysis was motivated by the need for a reliable, realistic sea ice climatology for use in climate model simulations, for which both the variability and absolute values of extent and concentration are important. We found that, while there are significant discrepancies in absolute concentrations, the major modes of variability derived from all records were essentially the same

XMM-Newton spectroscopy of an X-ray selected sample of RL AGNs

This paper presents the X-ray spectroscopy of an X-ray selected sample of 25 radio-loud (RL) AGNs extracted from the XBSS sample. The main goal is to study the origin of the X-ray spectral differences usually observed between radio-loud and radio-quiet (RQ) AGNs. To this end, a comparison sample of 53 RQ AGNs has been also extracted from the same XBSS sample and studied together with the sample of RL AGNs. We have focused the analysis on the distribution of the X-ray spectral indices of the power-law component that models the large majority of the spectra in both samples. We find that the mean X-ray energy spectral index is very similar in the 2 samples and close to alpha_X~1. However, the intrinsic distribution of the spectral indices is significantly broader in the sample of RL AGNs. In order to investigate the origin of this difference, we have divided the RL AGNs into blazars and ``non-blazars'', on the basis of the available optical and radio information. We find strong evidence that the broad distribution observed in the RL AGN sample is mainly due to the presence of the blazars. Furthermore, within the blazar class we have found a link between the X-ray spectral index and the value of the radio-to-X-ray spectral index suggesting that the observed X-ray emission is directly connected to the emission of the relativistic jet. This trend is not observed among the ``non-blazars'' RL AGNs. This favours the hypothesis that, in these latter sources, the X-ray emission is not significantly influenced by the jet emission and it has probably an origin similar to the RQ AGNs. Overall, the results presented here indicate that the observed distribution of the X-ray spectral indices in a given sample of RL AGNs is strongly dependent on the amount of relativistic beaming present in the selected sources.Comment: 18 pages, 10 figures, accepted for publication in A&

A lambda = 1.3 mm and 2 mm molecular line survey towards M82

We study the chemical complexity towards the central parts of the starburst galaxy M82, and investigate the role of certain molecules as tracers of the physical processes in the galaxy circumnuclear region. We carried out a spectral line survey with the IRAM-30m telescope towards the northeastern molecular lobe of M82. It covers the frequency range between 129.8 GHz and 175.0 GHz in the 2 mm atmospheric window, and between 241.0 GHz and 260.0 GHz in the 1.3 mm atmospheric window. Sixty-nine spectral features corresponding to 18 different molecular species are identified. In addition, three hydrogen recombination lines are detected. The species NO, H2S, H2CS, NH2CN, and CH3CN are detected for the first time in this galaxy. Assuming local thermodynamic equilibrium, we determine the column densities of all the detected molecules. We also calculated upper limits to the column densities of fourteen other important, but undetected, molecules, such as SiO, HNCO, or OCS. We compare the chemical composition of the two starburst galaxies M82 and NGC253. This comparison enables us to establish the chemical differences between the products of the strong photon-dominated regions (PDRs) driving the heating in M82, and the large-scale shocks that influence the properties of the molecular clouds in the nucleus of NGC253. Overall, both sources have different chemical compositions. Some key molecules highlight the different physical processes dominating both central regions. Examples include CH3CCH, c-C3H2, or CO+, the abundances of which are clearly higher in M82 than in NGC253, pointing at photodissociating regions. On the other hand, species such as CH2NH, NS, SiO, and HOCO+ have abundances of up to one order of magnitude higher in NGC253 than in M82.Comment: Accepted for publication in A&A. 19 pages, 8 figures, 3 table

Personalized therapy for mycophenolate:Consensus report by the international association of therapeutic drug monitoring and clinical toxicology

When mycophenolic acid (MPA) was originally marketed for immunosuppressive therapy, fixed doses were recommended by the manufacturer. Awareness of the potential for a more personalized dosing has led to development of methods to estimate MPA area under the curve based on the measurement of drug concentrations in only a few samples. This approach is feasible in the clinical routine and has proven successful in terms of correlation with outcome. However, the search for superior correlates has continued, and numerous studies in search of biomarkers that could better predict the perfect dosage for the individual patient have been published. As it was considered timely for an updated and comprehensive presentation of consensus on the status for personalized treatment with MPA, this report was prepared following an initiative from members of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT). Topics included are the criteria for analytics, methods to estimate exposure including pharmacometrics, the potential influence of pharmacogenetics, development of biomarkers, and the practical aspects of implementation of target concentration intervention. For selected topics with sufficient evidence, such as the application of limited sampling strategies for MPA area under the curve, graded recommendations on target ranges are presented. To provide a comprehensive review, this report also includes updates on the status of potential biomarkers including those which may be promising but with a low level of evidence. In view of the fact that there are very few new immunosuppressive drugs under development for the transplant field, it is likely that MPA will continue to be prescribed on a large scale in the upcoming years. Discontinuation of therapy due to adverse effects is relatively common, increasing the risk for late rejections, which may contribute to graft loss. Therefore, the continued search for innovative methods to better personalize MPA dosage is warranted.</p

Peri-operative red blood cell transfusion in neonates and infants: NEonate and Children audiT of Anaesthesia pRactice IN Europe: A prospective European multicentre observational study

BACKGROUND: Little is known about current clinical practice concerning peri-operative red blood cell transfusion in neonates and small infants. Guidelines suggest transfusions based on haemoglobin thresholds ranging from 8.5 to 12 g dl-1, distinguishing between children from birth to day 7 (week 1), from day 8 to day 14 (week 2) or from day 15 (≥week 3) onwards. OBJECTIVE: To observe peri-operative red blood cell transfusion practice according to guidelines in relation to patient outcome. DESIGN: A multicentre observational study. SETTING: The NEonate-Children sTudy of Anaesthesia pRactice IN Europe (NECTARINE) trial recruited patients up to 60 weeks' postmenstrual age undergoing anaesthesia for surgical or diagnostic procedures from 165 centres in 31 European countries between March 2016 and January 2017. PATIENTS: The data included 5609 patients undergoing 6542 procedures. Inclusion criteria was a peri-operative red blood cell transfusion. MAIN OUTCOME MEASURES: The primary endpoint was the haemoglobin level triggering a transfusion for neonates in week 1, week 2 and week 3. Secondary endpoints were transfusion volumes, 'delta haemoglobin' (preprocedure - transfusion-triggering) and 30-day and 90-day morbidity and mortality. RESULTS: Peri-operative red blood cell transfusions were recorded during 447 procedures (6.9%). The median haemoglobin levels triggering a transfusion were 9.6 [IQR 8.7 to 10.9] g dl-1 for neonates in week 1, 9.6 [7.7 to 10.4] g dl-1 in week 2 and 8.0 [7.3 to 9.0] g dl-1 in week 3. The median transfusion volume was 17.1 [11.1 to 26.4] ml kg-1 with a median delta haemoglobin of 1.8 [0.0 to 3.6] g dl-1. Thirty-day morbidity was 47.8% with an overall mortality of 11.3%. CONCLUSIONS: Results indicate lower transfusion-triggering haemoglobin thresholds in clinical practice than suggested by current guidelines. The high morbidity and mortality of this NECTARINE sub-cohort calls for investigative action and evidence-based guidelines addressing peri-operative red blood cell transfusions strategies. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02350348

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead